0.25
+0.0073(+2.99%)
Currency In USD
| Previous Close | 0.24 |
| Open | 0.25 |
| Day High | 0.26 |
| Day Low | 0.24 |
| 52-Week High | 3.49 |
| 52-Week Low | 0.22 |
| Volume | 525,357 |
| Average Volume | 1.04M |
| Market Cap | 11.59M |
| PE | -0.18 |
| EPS | -1.4 |
| Moving Average 50 Days | 0.3 |
| Moving Average 200 Days | 1.15 |
| Change | 0.01 |
If you invested $1000 in Cellectar Biosciences, Inc. (CLRB) 10 years ago, it would be worth $0.09 as of May 09, 2025 at a share price of $0.252. Whereas If you bought $1000 worth of Cellectar Biosciences, Inc. (CLRB) shares 5 years ago, it would be worth $17.11 as of May 09, 2025 at a share price of $0.252.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Cellectar Biosciences to Report First Quarter Financial Results and Host a Conference Call on Tuesday, May 13, 2025
GlobeNewswire Inc.
May 07, 2025 12:05 PM GMT
FLORHAM PARK, N.J., May 07, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today
Cellectar Announces Plan to Explore Strategic Alternatives
GlobeNewswire Inc.
Apr 30, 2025 12:05 PM GMT
FLORHAM PARK, N.J., April 30, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, tod
Cellectar Biosciences to Present at the 37th Annual Roth Conference
GlobeNewswire Inc.
Mar 11, 2025 12:05 PM GMT
FLORHAM PARK, N.J., March 11, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, tod